share_log

Apyx Medical Submits 510(k) Premarket Notification For Renuvion APR Handpiece To FDA, Supported By Clinical Study And Real-World Evidence

Apyx Medical Submits 510(k) Premarket Notification For Renuvion APR Handpiece To FDA, Supported By Clinical Study And Real-World Evidence

Apyx 醫療向美國食品藥物管理局 (FDA) 提交 510 (k) 關於雷諾威 APR 手機的上市前通知,並得到臨床研究和實際證據的支持
Benzinga Real-time News ·  2023/02/01 07:38

Apyx Medical Submits 510(k) Premarket Notification For Renuvion APR Handpiece To FDA, Supported By Clinical Study And Real-World Evidence

Apyx Medical向FDA提交Renuvion APR手機的510(K)售前通知,得到臨床研究和現實證據的支持

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論